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A B S T R A C T
Background: Memory deﬁcits and age-related memory loss are currently two signiﬁcant concerns in older adults.
In Iranian herbal medicine, there are some prescriptions for memory improvement.
Objective: This study was designed to investigate the eﬀect of tablet containing Boswellia serrata (BS) extract and
Mellisa oﬃcinalis (MO) extract on memory of the older adults.
Method: This is a randomized, parallel, double-blind, placebo-controlled clinical trial that performed among 70
older adults who referred to healthcare centers of Kashan University of Medical Sciences, Iran. Subjects were
randomly assigned to receive either tablets (n=35) or placebo (n=35) for a month (n=30). Data were
collected using a demographic questionnaire and the Wechsler Memory Scale-Revised (WMS-R). Data were
analyzed using Chi-square, independent-samples t-tests, paired t-test, repeated measure ANOVA, and ANCOVA
using SPSS v13.
Result: Participants' baseline characteristics were similar in the two groups. The study was completed by 53
participants. However, as the analysis was based on an intention-to treat approach, all 70 older adults were
included in the ﬁnal analysis. Comparison of the two groups with showed that the total scores of the WMS-R and
the subscales, including auditory immediate, immediate memory, visual immediate and working memory, were
increased after consumption of the containing BS and MO tablets (p < 0.0001).
Conclusion: The BS and MO tablet in older adults can be beneﬁcial on improvement of memory. This is still
necessary to investigate eﬀects and durability of the tablets on older adults with memory impairments in future
studies.
1. Background
According to WHO, older adults are deﬁned as people over age 65
years (WHO, 2016). The world population is increasingly aging. The
number of the older adults in the world is estimated to be 82 million by
2050 (de Rezende, Rey-Lopez, Matsudo, & do Carmo Luiz, 2014). In this
group, aging can lead to health problems, such as cognitive impair-
ments, chronic diseases, and physiological disorders (Masoudi Alavi,
Safa, & Abedzadeh-Kalahroudi, 2014). The older adults are often as-
sociated with changes in the neurocognitive abilities (Canivet et al.,
2015). Occurrence rate of memory deﬁcits is approximately 21.5–71.3
per 1000 years in older adults. The prevalence of dementia in the older
adults population is about 1% to 2% per year (Eshkoor, Hamid, Mun, &
Ng, 2015).
New techniques have been developed for memory enhancement and
prevention from age-related memory loss (Mahboubi, Taghizadeh,
Talaei, Takht Firozeh, & Tamtaji, 2016). In General, pharmacological
and non-pharmacological treatments are available, especially for im-
pairment of memory. However, they are not eﬀective in all cases and
cause side eﬀects, especially in long-term administration. Herbal med-
icine is commonly used for treating diseases, such as amnesia as well as
reinforcing memory (Jalili, Salahshoor, Pourmotabbed et al., 2014).
Some of the most common herbs used for improving memory perfor-
mance are Elaeagnus Angustifalia (Hamidpour et al., 2017), Ficus
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Carica (Subash et al., 2016), Crous Sativus (Khazdair, Boskabady,
Hosseini, Rezaee, & Tsatsakis, 2015), Olive oil (Lehert, Villaseca,
Hogervorst, Maki, & Henderson, 2015), Ginkgo (Stackman et al., 2003)
and Huperzine (Malkova, Kozikowski, & Gale, 2011). Iranian Tradi-
tional Medicine recommends MO and BS for memory improvement
abilities (Mahboubi et al., 2016). In 10th century, Avicenna, the Persian
physician, introduced the MO and BS for treating neurological disorder
in The Canon of Medicine (The Law of Medicine) (Hosseini-Sharifabad,
Kamali-Ardakani, & Hosseini-Sharifabad, 2016).
Few interventional studies have examined the eﬀects of BS on
memory. Findings from these studies indicated that memory increased
after a period of BS administration (Jalili, Salahshoor, Moradi et al.,
2014; Hosseini et al., 2010). BS has a botanical origin and consists of
triterpenes (α- and β-boswellic acids and l upeolic acid), essential oils,
and polysaccharides (Catanzaro et al., 2015). Also several studies have
shown that MO might lead to improvement of memory (Ozarowski
et al., 2016; Kennedy et al., 2003; Soodi, Naghdi, Hajimehdipoor,
Choopani, & Sahraei, 2014). MO exhibits acetylcholine receptor ac-
tivity (Akbarzadeh et al., 2015) may treat the cholinergic dysfunction in
Alzheimer’s disease (Kennedy et al., 2003). An earlier study showed
that a joint administration of the BS and MO in animals was more ef-
fective than a single BS or MO in memory improvement (Mahboubi
et al., 2016). According to the authors' knowledge, there is no study on
eﬀects of joint BS and MO on human's memory. This study was con-
ducted to investigate the tablet containing BS and MO on older adults'
memory.
2. Methods
The present study was a randomized double-blind parallel con-
trolled trial conducted from August to September 2015. The partici-
pants were 70 older adults referred to healthcare centers associated
with Kashan University of Medical Sciences, Kashan, Iran. For esti-
mating sample size, we used the standard formula suggested for parallel
clinical trials and considered the type 1 error (α) of 0.05 and type 2
Fig. 1. Consort ﬂow diagram of the study.
Table 1
Demographic characteri stics in intervention and control groups.1
Intervention group
(N=35)
Control group
(N=35)
P2
Age 67.14 ± 6.28 65.62 ± 5.33 0.07
Sex 0.31
Female 23 (65.71%) 20 (57.14%)
Male 12 (34.29%) 15 (42.86%)
Marital status 0.35
Single 1 (2.86%) 3(8.57%)
Married 28 (80.00%) 23 (65.71%)
Widow 6 (17.14%) 9 (25.72%)
Job 0.74
Self-employment 2 (5.72%) 3 (8.57%)
Retired 10 (28.57%) 12 (34.29%)
Homemaker 23 (65.71%) 20 (57.14%)
Education Level 0.80
Illiterate 21(60.00%) 19(54.29%)
Elementary 9(25.71%) 10(28.57%)
Middle school 3 (8.57%) 5 (14.28%)
Diploma and higher 2 (5.72%) 1 (2.86%)
1 Values are means ± SDs or n (%).
2 Obtained from a chi-square test, except for age, which was obtained an Independent
samples student's t-test.
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error (b) of 0.20 (power= 80%). According to evidence (Archier &
Vieillescazes, 2000), we used 10 as the s1 and 10 as s2 as a key variable.
Therefore, we needed 30 participants in each group. Considering 5
dropouts in each group, the ﬁnal sample size was determined to be 35
participants per group. Inclusion criteria were (a) age 60–74 years, (b)
full conscious, (c) speak pension, (d) no history of psychological dis-
order and Alzheimer’s disease based on medical records, and (e) no
history of allergy to herbal medicine. Exclusion criteria included: irre-
gular consumption of tablets (missing two or more consecutive do-
sages), inaccessibility of the participants (relocation, hospitalization,
and a lack of follow up) and an incidence of side eﬀects (such as
headache, nausea, vomiting and digestive problems).
2.1. Sampling
In this study, we employed multi-stage random sampling. In the ﬁrst
stage, Kashan city was divided into four regions: north, south, east, and
west. In the second stage, one healthcare center from each region was
randomly selected. Consequently, a simple random sampling method
was used to reach sample size of participants in each center (n=30).
The second author explained the study purposes, and provided in-
formation about the tablets; beneﬁts and side eﬀects. Then, the parti-
cipants who had inclusion criteria and signed the informed consent
were selected. Another researcher (psychologist) interviewed the par-
ticipants in private room and completed Wechsler Memory Scale. Then
eligible older adults were divided into two intervention (35 cases) and
control (35 cases) groups using block random allocation. The third
author performed the Block random allocation with four blocks and one
code was assigned for each participant. Random assignment was per-
formed using computer-generated random numbers.
2.2. Plant extracts and physiochemical analysis
Flowering aerial parts of MO was collected from a research farm in
the Medicinal Plant Research Center of Barij (Kashan, Iran) in August
2012. The voucher specimen was identiﬁed by research institute of
Forest and Rangelands, Tehran, Iran, and deposited in the Herbarium of
agriculture department, Medicinal Plant Research Center of Barij,
Kashan, Iran (number 166.1). Batch Number: BS10017 (BS) was pur-
chased from Natural Remedies Pvt. Ltd. Bangalore Karnataka, India.
Rosmarinic acid of MO extract was detected by HPLC method (Wang,
Provan, & Helliwell, 2004). The amount of total boswellic acids, 11-
keto- boswellic acid and acetyl-11-keto -boswellic acid were de-
termined by a calibration curve (Shah, Rathod, Suhagia, Pandya, &
Parmar, 2008).
2.3. Boswellia serrata (BS) and Melissa Oﬃcinalis (MO) extract tablets
The participants received the BS and MO in the form of tablet.
Tablets were produced by Barij Essence Pharmaceutical Company
(Kashan, Iran). Sixty tablets containing 290mg dried extract of MO is
that had been standardized by rosmarinic acid (8.5% w/w) and 27mg
of dried extract BS that had been standardized by boswellic acid and
acety l-11-keto-boswellic acids were 70, 4.67 and 1.85% w/w, respec-
tively. Furthermore, tablets contained Avicel, corn starch, Lactose
mono hydrate, and magnesium stearate adjuvant.
2.4. Intervention
The tablets and placebo were classiﬁed and coded by formulation
unit of Research Center of Barij (Kashan, Iran). The placebo was pre-
pared in the same color, shape, size, and packaging style as the tablets.
The codes were considered for each package and the participants and
the researchers were not aware of the content of the package at the time
of the study. In the ﬁrst visit, the participants received 30 tablets for
15 days. In the second visit, they received more 30 tablets. In each visit,
researcher answered to the participants' questions. In the intervention
group received two tablets (containing BS and MO) per day in the
morning and night and the participants in the placebo group received
two placebos per day for one month (n=60). For follow-up, the par-
ticipants were contacted using telephone every week by the second
author. The psychologist completed the WMS-R test for two groups in
the healthcare centers after a month.
Table 2
Relation between mean scores of total memory and subscales memory in two groups at the beginning of the study and at the end of the study.1
at the beginning of the study at the end of the study
Intervention group Control group P2 Intervention group Control group P2
auditory immediate 31.32 ± 13.74 30.63 ± 9.56 0.84 48.25 ± 12.88 34 ± 6.55 0.0001
visual immediate 49.93 ± 9.73 51.04 ± 10.59 0.69 57.25 ± 8.95 54.54 ± 15.71 0.33
immediate memory 81. 25 ± 20.91 80.77 ± 18.77 0.93 102.38 ± 20.51 85.45 ± 15.71 0.002
working memory 16.03 ± 4.72 18 ± 3.2 0.09 19.67 ± 4.44 20.36 ± 2.8 0.52
Total memory 178.54 ± 44.66 181.36 ± 37.45 0.81 227.58 ± 40.22 194.36 ± 27.61 0.002
1 Calues are means ± SDs.
2 Obtained from an independent samples student's t-test.
Table 3
Total memory and subscales memory at study baseline and after 4-wk intervention in elderly that received either MO & BS tablet or placebo.1
Intervention group Control group
Before After change P2 Before After change P2 P3
auditory immediate 31.32 ± 13.74 48.25 ± 12.88 16.93 ± 12.29 0.0001 30.63 ± 9.56 34 ± 6.55 3.36 ± 12.12 0.21 0.0001
visual immediate 49.93 ± 9.73 57.25 ± 8.95 7.32 ± 6.96 0.0001 51.04 ± 10.59 54.54 ± 15.71 3.50 ± 12.15 0.19 0.0001
immediate memory 81.25 ± 20.91 102.38 ± 20.51 21.12 ± 9.20 0.0001 80.77 ± 18.77 85.45 ± 15.71 4.68 ± 17.22 0.21 0.0001
working memory 16.03 ± 4.72 19.67± 4.44 3.64 ± 2.51 0.0001 18 ± 3.21 20.36 ± 2.8 2.36 ± 3.95 0.01 0.0001
Total memory 178.54 ± 44.66 227.58 ± 40.22 49.03 ± 21.31 0.0001 181.36 ± 37.45 194.36 ± 27.61 13 ± 35.72 0.11 0.0001
1 Values are means ± SDs.
2 Obtained from a pair t-test.
3 Obtained from repeated measure ANOVA.
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2.5. Instrument
Two questioners, socio demographic characteristics, including: age,
sex, marital status, job, and education level and the Wechsler Memory
Scale-Revised (WMS-R), were used. Compared to the original WMS, the
WMS-R has a broader normative base; includes more subscales such as
Visual Span and Figural Memory.
In the WMS-R version, there are eight primary indexes, including
auditory immediate (verbal), visual immediate (visual), immediate
memory, auditory delayed, visual delayed, auditory reception delayed,
general memory, and working memory (Franzen, Wilhelm, & Haut,
1995). In this study, four subscales were used based on education and
cognitive status of the participants including, (WHO, 2016) Auditory
immediate, (Logical Memory Ι+Visual Paired Associates Ι). In the
auditory immediate, one short story is presented orally and the ex-
aminee is asked to retell story from memory immediately after hearing
it. (de Rezende et al., 2014) Visual immediate (faces Ι+family picture
Ι). In the visual, a series of ﬁve designs is shown, one at a time, each for
10 s. After presenting each design, the examinee is asked to draw the
design from memory. (Masoudi Alavi et al., 2014) Immediate memory
(Logical Memory Ι+ Verbal Paired Associates Ι+ faces Ι+family
picture Ι). In the immediate memory the examiner reads 10 or 14 word
pairs to the examinee. Then, the examiner reads the ﬁrst word of each
pair, and asks the examinee to provide the corresponding word.
(Canivet et al., 2015) Working memory (letter-number sequen-
cing+ spatial span). In the working memory the examinee is brieﬂy
shown a series of abstract symbols on a page and then asked to select
the symbols from an array of symbols, in the same order they were
presented on the previous page.
The total score of WMS-R ranged from 0 to 455 and subscales score
included: auditory immediate 0 − 73, visual immediate 0 − 112, im-
mediate memory 0–185, and working memory 0 − 85. The validity of
the Persian version of the WMS-R was previously established by Orangi
et al. The Cronbach’s alpha of the instrument was 0.98 (Orangi,
Atefvahid, & Ashayeri, 2002).
2.6. Ethical considerations
This study was approved by the Institutional Review Board and the
ethics committee of Kashan University of Medical Sciences (approval
number: 94013). The research objectives were explained to the parti-
cipants and a written informed consent was obtained. The participants
were informed about voluntary participation and the right for with-
drawal at any time. They were assured that their anonymity will be
protected and their personal information will be kept conﬁdential. This
study was registered at the Iranian Registry of Clinical Trials (IRCT)
with registration code IRCT 2015102114086N6.
2.7. Data analysis
We used the Kolmogorov–Smirnov test to examine the normal dis-
tribution of the variables. Log transformation was used for non-nor-
mally distributed variables. The analyses were performed on the basis
of an intention-to-treat approach. Missing values were controled using
the Last Observation Carried Forward (LOCF) method. Descriptive
statistics (mean, standard deviation, frequency, and percentage) were
conducted. The categorical variables were analyzed using the chi-
square test. Paired t-test was used to compare the quantitative variables
with in groups. To determine the eﬀects of BS and MO on the total
memory and subscales of memory, we used One-Way Repeated
Measures Analysis of Variance One-Way ANOVA to control eﬀects of
confounders. We adjusted all analyses for general characteristics to
avoid potential biases. This analysis was done using the ANCOVA. The
level of signiﬁcance was set at 0.05. Statistical analyses were performed
using SPSS version 13 (SPSS, Chicago, IL, USA).
3. Result
The total attrition rate for the intervention and control groups was
17 participants. In the intervention group, this rate was due to side
eﬀects (one digestive side eﬀect and one allergy and ﬂushing) and
withdrawal from the study (two participants). In the control group, this
rate resulted from side eﬀects (one digestive side eﬀect and one allergy)
and withdrawal from the study (11 participants, 5 irregular consump-
tion of 2 hospitalizations, 4 relocation and no response to phone calls).
Finally, Data from 53 participants were analyzed (Fig. 1). However, as
the analysis was done based on an intention-to-treat approach, the data
from all participants (35 in each group) were included in the ﬁnal
analyses. For those who completed the trial (n= 53), the tablet counts
suggested 100% adherence in both group.
The mean age in the intervention group was 67.14 ± 6.28 and in
the control group was 65.62 ± 5.33. About 65.71% of the participants
in the intervention group and 57.14% in the control group were female.
The results indicated that there was no signiﬁcant diﬀerence between
the two groups in terms of the socio demographic variables, including
age, sex, marital status, job, and education level (p > 0.05) (Table 1).
At the beginning of the study, results of the independent sample t-
tests revealed that there was no signiﬁcant diﬀerence between the two
groups' in terms of the mean score of the total memory and the sub-
scales of memory, auditory immediate, visual immediate, immediate
memory, and working memory (p > 0.05). Furthermore, a signiﬁcant
diﬀerence was found between the two groups in terms of the auditory
immediate (p < 0.0001), immediate memory (p < 0.002) and total
memory (p < 0.002) after the intervention (Table 2).
Results of the paired t-test showed that the total memory score and
its subscales were increased after the intervention (p < 0.0001). The
results also showed a signiﬁcant increase in working memory score in
the control group at the end of the study (Table 3).
Diﬀerences between the two groups were not signiﬁcant in terms of
auditory immediate, visual immediate, immediate memory, and
working memory. BS and MO administration, compared to placebo, led
to a signiﬁcant increase in auditory immediate (48.25 ± 12.88 vs
34 ± 6.55, p < 0.0001) and visual immediate (57.25 ± 8.95 vs
54.54 ± 15.71, p < 0.0001) scores. In addition, after the adminis-
tration of BS and MO tablets, we observed a signiﬁcant increase in the
immediate memory (102.38 ± 20.51 vs 85.45 ± 15.71, p < 0.0001)
and working memory (19.67 ± 4.44 vs 20.36 ± 2.8, p < 0.0001)
scores compared to placebo. Furthermore, it resulted in a signiﬁcant
increase in the total memory score (227.58 ± 40.22 vs
194.36 ± 27.61, p < 0.0001) (Table 3). When we adjusted the ana-
lyses for the participants' general characteristics, no signiﬁcant diﬀer-
ences were observed in terms of age (p= 0.12), sex (p=0.37), Marital
status (p= 0.88), Job (p= 0.19) and Education Level (p= 0.11).
4. Discussion
This study showed that, BS and MO tablet improved the memory
scores in the participants. To the best of our knowledge, this is the ﬁrst
study to examine the eﬀects of BS and MO supplementation on memory
in older adults.
With aging, the likelihood of developing memory loss increases.
About 40% of older adults have age-associated memory impairment
(Eshkoor et al., 2015). Cognitive impairment and Alzheimer’s dementia
signiﬁcantly increase as the population ages (Vigil, Mizuno, Lucchesi,
Valls-Comamala, & Giese, 2017). Therefore, it is important to prevent
the diseases and their complications. Our study demonstrated that the
BS and MO tablets for a month in participants led to a signiﬁcant in-
crease in auditory immediate and immediate memory compared to
placebo. Previous studies have reported the positive eﬀects of single
MO or BS supplementation on memory in older adults; however the
combined eﬀects of BS and MO supplementation have not been as-
sessed. In line with our study, Jalili, Salahshoor, Moradi et al. (2014)
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showed that BS has positively resulted in improved learning ability.
Improvement of memory after BS consumption was shown in other
studies (Hosseini-Sharifabad et al., 2016; Hosseini et al., 2010;
Mahmoudi et al., 2011). BS is known as a substance for improvement of
memory and prevention of Alzheimer's disease (Rainer, 1996). Ac-
cording to pharmacokinetic studies, there are substances in BS that are
associated with memory storage (Kruger et al., 2008). Other researchers
reported a positive eﬀect of MO supplementation on long-term memory
(Ozarowski et al., 2016; Akbarzadeh et al., 2015; Bayat et al., 2012).
Moreover, they showed that MO extract is eﬀective in management of
mild to moderate Alzheimer’s disease and MO has CNS acetylcholine
receptor activities, which can modulate mood and cognitive perfor-
mance (Akhoondzadeh, Jalalmanesh, & Hojjati, 2014).
The ﬁndings of this study showed, the administration of BS and MO
tablet improved total memory score and subscales in the participants.
Our ﬁndings were in line with Mahboubi et al. (Mahboubi et al., 2016).
Mahboubi et al. indicated that the memory ability to improve memory
in an animal model after MO and BS intake. The mechanisms, which
can explain this result is that the intake of BS supplements may aﬀect
various protein kinase activities, calcium mobilization, and signaling
pathways (Mahmoudi et al., 2011). Ozarowski et al. reported that MO
extract can exhibit cholinergic receptor-binding properties and inhibit
acetyl cholinesterase; therefore, learning may enhance (Ozarowski
et al., 2016).
Our study had limitations. The intervention was performed in a
limited time
While interpreting our ﬁndings, some limitations need to be con-
sidered. The intervention in the current study was of relatively short
duration. Long-term interventions may show other eﬀects on older
adult memory. In this study, the participants had no history of psy-
chological disorders and Alzheimer’s disease; therefore, generalizability
of our ﬁndings to the general population of older adults is limited.
Another limitation of this study was a lack of follow up for a longer
period. It is recommended that in future studies follow up be considered
for two, four, and six months after using of the tablets. Moreover, it is
recommended that, in the future studies, researchers recruit a random
sample of older adults.
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